TPIDB > Principal Investigator
Principal Investigator
National Taiwan University Hospital
(在職)
Division of Otolaryngology
Division of Hematology & Oncology
更新時間：2024-03-18
婁培人Lou, Pei-Jen
- Principal Investigator
- Clinical Trial Experience (year) 17 years 9 個月
Publication
19Publications
1
Chen TC, Chang HL, Yang TL, Lou PJ, Chang YL, Ko JY, Wang CP. Impact of dysplastic surgical margins for patients with oral squamous cell carcinoma. Oral Oncol. 2019 Oct;97:1-6. doi: 10.1016/j.oraloncology.2019.07.015. Epub 2019 Jul 31. PMID: 31421465.
2
Chen TC, Wu CT, Ko JY, Yang TL, Lou PJ, Wang CP, Chang YL. Clinical characteristics and treatment outcome of oropharyngeal squamous cell carcinoma in an endemic betel quid region. Sci Rep. 2020 Jan 16;10(1):526. doi: 10.1038/s41598-019-57177-1. PMID: 31949181; PMCID: PMC6965138.
3
Chen TC, Wu CT, Wang CP, Lou PJ, Ko JY, Chang YL. The differences of immunologic and TP53 mutant phenotypes between synchronous and metachronous head and neck cancer and esophageal cancer. Oral Oncol. 2020 Dec;111:104945. doi: 10.1016/j.oraloncology.2020.104945. Epub 2020 Aug 5. PMID: 32769036.
4
Chen Y, Lee YA, Li S, Li Q, Chen CJ, Hsu WL, Lou PJ, Zhu C, Pan J, Shen H, Ma H, Cai L, He B, Wang Y, Zhou X, Ji Q, Zhou B, Wu W, Ma J, Kawakita D, Boffetta P, Zhang ZF, Dai M, Hashibe M. Body mass index and the risk of head and neck cancer in the Chinese population. Cancer Epidemiol. 2019 Jun;60:208-215. doi: 10.1016/j.canep.2019.04.008. Epub 2019 May 7. PMID: 31071526.
5
Coghill AE, Pfeiffer RM, Proietti C, Hsu WL, Chien YC, Lekieffre L, Krause L, Teng A, Pablo J, Yu KJ, Lou PJ, Wang CP, Liu Z, Chen CJ, Middeldorp J, Mulvenna J, Bethony J, Hildesheim A, Doolan DL. Identification of a Novel, EBV-Based Antibody Risk Stratification Signature for Early Detection of Nasopharyngeal Carcinoma in Taiwan. Clin Cancer Res. 2018 Mar 15;24(6):1305-1314. doi: 10.1158/1078-0432.CCR-17-1929. Epub 2018 Jan 4. Erratum in: Clin Cancer Res. 2020 Jul 1;26(13):3496. PMID: 29301829; PMCID: PMC5856605.
6
Fang YY, Wang CP, Chen YJ, Lou PJ, Ko JY, Lin JJ, Chen MR, Lai YH. Physical activity and fitness in survivors of head and neck cancer. Support Care Cancer. 2021 Nov;29(11):6807-6817. doi: 10.1007/s00520-021-06192-y. Epub 2021 May 17. PMID: 33997941.
7
Hashibe M, Li Q, Chen CJ, Hsu WL, Lou PJ, Zhu C, Pan J, Shen H, Ma H, Cai L, He B, Wang Y, Zhou X, Ji Q, Zhou B, Wu W, Ma J, Boffetta P, Zhang ZF, Dai M, Lee YA. Involuntary smoking and the risk of head and neck cancer in an East Asian population. Cancer Epidemiol. 2019 Apr;59:173-177. doi: 10.1016/j.canep.2019.01.020. Epub 2019 Feb 19. PMID: 30785070.
8
Hsu WL, Chien YC, Huang YT, Yu KJ, Ko JY, Lin CY, Tsou YA, Leu YS, Liao LJ, Chang YL, Su JY, Liu Z, Wang CP, Terng SD, Hua CH, Lee JC, Yang TL, Kate Hsiao CH, Wu MS, Tsai MH, Liu MJ, Lou PJ, Hildesheim A, Chen CJ; GEV-NPC Study Group. Cigarette smoking increases the risk of nasopharyngeal carcinoma through the elevated level of IgA antibody against Epstein-Barr virus capsid antigen: A mediation analysis. Cancer Med. 2020 Mar;9(5):1867-1876. doi: 10.1002/cam4.2832. Epub 2020 Jan 10. PMID: 31925935; PMCID: PMC7050088.
9
Hu CC, You KL, Tsai LY, Fang YY, Jhang SY, Lou PJ, Wang CP, Ko JY, Lee YH, Lai YH. Validation of the Supportive Care Needs Survey Screening Tool Chinese Version for Patients With Head and Neck Cancer in Taiwan. J Nurs Res. 2019 Dec;27(6):e50. doi: 10.1097/JNR.0000000000000360. PMID: 31688277.
10
Kao HF, Lou PJ. Immune checkpoint inhibitors for head and neck squamous cell carcinoma: Current landscape and future directions. Head Neck. 2019 Oct;41 Suppl 1:4-18. doi: 10.1002/hed.25930. PMID: 31573752.
1
2
